Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00266916 · ClinicalTrials.gov registry record
Percutaneous Interventions in Adults With CHD
A clinical trial, sponsored by Children's Healthcare of Atlanta.
- Terminated
- Registry status
- 9
- Enrollment target
NCT00266916 is a clinical trial that was terminated before completion, run by Children's Healthcare of Atlanta. The registered enrollment target is 9 participants.
The verdict
NCT00266916 was terminated before completion, sponsored by Children's Healthcare of Atlanta.
- TERMINATED
- Registry status
- 9 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine the clinical benefits of percutaneous intervention to improve pulmonary blood flow on oxygen saturations, symptoms, exercise tolerance and hematocrit in patients with complex cyanotic congenital heart disease who are not candidates for surgical repair.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 1996-01 |
| Est. Completion | 2006-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00266916
The ClinicalTrials.gov registry entry for NCT00266916 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Healthcare of Atlanta, which has 80 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00266916 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00266916 about?
NCT00266916 is a clinical study titled "Percutaneous Interventions in Adults With CHD". The primary objective of this study is to determine the clinical benefits of percutaneous intervention to improve pulmonary blood flow on oxygen saturations, symptoms, exercise tolerance and hematocrit in patients with complex cyanotic congenital heart disease who are not candidates for surgical rep...
What is the current status of trial NCT00266916?
This trial is currently terminated. The enrollment target is 9 participants. The study started on 1996-01. Estimated completion is 2006-08.
Who is sponsoring clinical trial NCT00266916?
This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.